What is claimed is:
1. An apparatus for working an injection hole of a fluid injection nozzle, the apparatus comprising:
a fluid injection nozzle having a valve body forming a fluid path inside thereof and having a valve seat and an orifice plate arranged at a front end face of the valve body, the orifice plate having at least one injection hole in a desired size with a divergent diameter from a fluid inlet to a fluid outlet, and a valve member for closing the fluid path by being seated on the valve seat and opening the fluid path by separating from the valve seat;
wherein a central axis line of the injection hole connecting a center of the fluid inlet of the injection hole to a center of the fluid outlet of the injection hole is inclined to a line perpendicular to a face of the orifice plate; and
wherein a first intersection and a second intersection of imaginary lines drawn from a first face and a second face of the injection hole, respectively, are inclined to the central axis line of the injection hole and are also inclined to the line perpendicular to the face of the orifice plate;
a die mounted with a plate-like material before working the injection hole of the fluid injection nozzle;
a punch substantially in a shape of a truncated circular cone, a shape of a front end portion of the punch is provided with a first inclination angle and a second inclination angle relative to the line perpendicular to the face of the plate-like material;
a punch guide having a support hole for slidably supporting the punch such that a central axis line of the punch is inclined to the line perpendicular to the face of the platelike material; and
a punch driving means for advancing the punch along the central axis line of the punch guide;
wherein the punch guide uses a die structure capable of receiving a side force (Fs) from the front end portion of the punch produced in working the injection hole when the central axis line of the injection hole is inclined to the line perpendicular to the face of the plate-like material.
2. The apparatus of working an injection hole of a fluid injection nozzle according to claim 1:
wherein a first inclination angle formed by the first intersection on a side of an obtuse angle formed by the central axis line of the injection hole and an end face of the fluid inlet side of the orifice plate, and the line perpendicular to the face of the orifice plate, is designated by a notation 1, and a second inclination angle formed by the second intersection on a side of an acute angle formed by the central axis line of the injection hole and the end face on the fluid inlet side of the orifice plate and the line perpendicular to the face of the orifice plate, is designated by a notation 2, wherein 1 is greater than or equal to 15, and wherein 1 is less than 2.
3. The apparatus of working an injection hole of a fluid injection nozzle according to claim 1:
wherein a sliding face of an inner face of the punch guide on which the front end portion of the punch slides, is provided with the first inclination angle relative to the line perpendicular to the face of the plate-like material; and
wherein a shape of a top portion of the front end portion of the punch is made parallel to the sliding face of the punch guide, the top portion of the front end portion of the punch guide also being parallel to the central axis line of the punch.
4. A method of working an injection hole of a fluid injection nozzle comprising the steps of:
holding a plate-like material between a die and a punch guide containing a punch;
extruding the plate-like material by advancing a front end portion of the punch into the plate-like material;
excluding a volume of the plate-like material by extruding the plate-like material into the die; and
removing forwardly of a face of the plate-like material, the volume of the extruded material.
5. The method of working an injection hole of a fluid injection nozzle according to claim 4 further comprising the steps of:
setting a clearance between the front end portion of the punch and the die in a predetermined range relative to a plate thickness of the plate-like material, and
removing the extruded portion by cutting, machining or grinding the extruded portion at a height consistent with the face of the plate-like material, after extrusion.
6. The method of working an injection hole of a fluid injection nozzle according to claim 4 further comprising the step of:
setting a clearance between the front end portion of the punch die to be equal to or smaller than a predetermined value, wherein during extrusion, the punch is pressed until the extruded portion is automatically separated from the plate-like material due to the clearance.
7. An apparatus for forming an injection hole of a fluid injection nozzle, the apparatus comprising:
a punch holder located adjacent to a die;
a plate-like material sandwiched between the punch holder and the die, the plate-like material defining a plurality of injection holes resulting in an orifice plate;
a punch located within a support hole of the punch holder, the punch having an end portion with a first peripheral portion defining a first angle 1, with a line perpendicular to a face of the plate-like material, the punch also having a second peripheral portion at the end portion defining a second angle 2, with the line perpendicular to a face of the plate-like material;
wherein the punch is subjected to a force (Fs) when the punch makes contact with the plate-like material, and wherein the force (Fs) is countered by a force (Fr), the force (Fr) being the reaction force to the force (Fs), wherein the canceling forces, (Fs) and (Fr) prevent a bending moment in the punch; and
wherein the injection holes are directed so that a first group sprays in a first direction and a second group sprays in a direction 180 degrees from the first group, the directions being fixed.
8. The apparatus for forming an injection hole of a fluid injection nozzle according to claim 7:
wherein a central axis line of the injection hole connecting a center of the fluid inlet of the injection hole to a center of the fluid outlet of the injection hole is inclined to a line perpendicular to a face of the orifice plate; and
wherein a first intersection and a second intersection of imaginary lines drawn from a first face and a second face of the injection hole, respectively, are inclined to a central axis line of the injection hole and are also inclined to the line perpendicular to the face of the orifice plate.
9. The apparatus for forming an injection hole of a fluid injection nozzle according to claim 8:
wherein a first inclination angle formed by the first intersection on a side of an obtuse angle formed by the central axis line of the injection hole and an end face of the fluid inlet side of the orifice plate, and the line perpendicular to the face of the orifice plate, is designated by a notation 1, and a second inclination angle formed by the second intersection on a side of an acute angle formed by the central axis line of the injection hole and the end face on the fluid inlet side of the orifice plate and the line perpendicular to the face of the orifice plate, is designated by a notation 2, wherein 1 is greater than or equal to 15degrees, and wherein 1 is less than 2.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
What is claimed is:
1. A formulation comprising pharmaceutically acceptable transfer factor, zinc and at least one pharmaceutically acceptable essential fatty acid.
2. The formulation of claim 1 further comprising Vitamin C and pharmaceutically acceptable yeast.
3. The formulation of claim 2 further comprising pharmaceutically acceptable ionic salts or chelates of calcium, phosphorous, selenium, iron, magnesium, manganese, copper, iodine, cobalt and molybdenum.
4. The formulation of claim 3 further comprising pharmaceutically acceptable lactic acid generating bacteria, yeast, montmorillonite and Vitamins A, B2, B6, B12, E and K.
5. The formulation of claim 4 further comprising pharmaceutically acceptable d-biotin, folic acid, niacin, Vitamin D3, pantothenic acid and thiamine.
6. The formulation of claim 5 further comprising pharmaceutically acceptable lysine, methionine, arginine and methyl sulfonyl methane.
7. A method of treating Cushings syndrome, Cushings disease, a benign tumor, onchoceriasis, hypothyroidism, or equine protozoal myelytis (EPM) in an animal comprising administering to the animal said formulation of claim 1 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor or symptoms of said Cushings disease or syndrome, onchoceriasis, hypothyroidism, or equine protozoal myelytis.
8. A method of treating Cushings syndrome, Cushings disease, a benign tumor, onchoceriasis, hypothyroidism, or equine protozoal myelitis in an animal comprising administering to the animal said formulation of claim 2 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor or symptoms of said Cushings disease or syndrome, onchoceriasis, hypothyroidism, or equine protozoal myelitis.
9. A method of treating Cushings syndrome, Cushings disease, a benign tumor, onchoceriasis, hypothyroidism, or equine protozoal myelitis in an animal comprising administering to the animal said formulation of claim 3 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor or symptoms of said Cushings disease or syndrome, onchoceriasis, hypothyroidism, or equine protozoal myelitis.
10. A method of treating Cushings syndrome, Cushings disease, a benign tumor, onchoceriasis, hypothyroidism, or equine protozoal myelitis in an animal comprising administering to the animal said formulation of claim 4 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor or symptoms of said Cushings disease or syndrome, onchoceriasis, hypothyroidism, or equine protozoal myelitis.
11. A method of treating Cushings syndrome, Cushings disease, a benign tumor, onchoceriasis, hypothyroidism, or equine protozoal myelitis in an animal comprising administering to the animal said formulation of claim 5 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor or symptoms of said Cushings disease or syndrome, onchoceriasis, hypothyroidism, or equine protozoal myelitis.
12. A method of treating Cushings syndrome, Cushings disease, a benign tumor, onchoceriasis, hypothyroidism, or equine protozoal myelitis in an animal comprising administering to the animal said formulation of claim 6 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor or symptoms of said Cushings disease or syndrome, onchoceriasis, hypothyroidism, or equine protozoal myelitis.
13. A method of treating inflamation or ulcers in an animal comprising administering to the animal said formulation of claim 1 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said inflamation or ulcers.
14. A method of treating inflamation or ulcers in an animal comprising administering to the animal said formulation of claim 2 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said inflamation or ulcers.
15. A method of treating inflamation or ulcers in an animal comprising administering said formulation of claim 3 to the animal in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said inflamation and ulcers.
16. A method of treating inflamation or ulcers in an animal comprising administering to the animal said formulation of claim 4 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said inflamation or ulcers.
17. A method of treating inflamation or ulcers in an animal comprising administering to the animal said formulation of claim 5 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said inflamation or ulcers.
18. A method of treating inflamation or ulcers in an animal comprising administering to the animal said formulation of claim 6 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said inflamation or ulcers.
19. A formulation comprising pharmaceutically acceptable transfer factor and a pharmaceutically acceptable lactic acid generating bacteria.
20. The formulation of claim 19 further comprising pharmaceutically acceptable yeast.
21. The formulation of claim 20 further comprising pharmaceutically acceptable montmorillinite.
22. The formulation of claim 21 further comprising at least one essential pharmaceutically acceptable fatty acid, pharmaceutically acceptable ionic salts or chelates of the elements calcium, phosphorous, selenium, iron, magnesium, manganese, copper, iodine, cobalt and molybdenum, yeast, Vitamins A, B2, B6, B12, C, E and K, d-biotin, folic acid, niacin, Vitamin D3, pantothenic acid and thiamine, lysine, methionine, arginine and methyl sulfonyl methane.
23. A method of treating flea bite dermatitis in an animal and feline leukemia in a cat comprising administering to the animal or cat said formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said dermatitis or said leukemia.
24. A method of treating flea bite dermatitis in an animal and feline leukemia in a cat comprising administering to the animal or cat said formulation of claim 20 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said dermatitis or said leukemia.
25. A method of treating bite dermatitis in an animal and feline leukemia in a cat comprising administering to the animal or cat said formulation of claim 21 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said dermatitis or said leukemia.
26. A method of treating flea bite dermatitis in an animal and feline leukemia in a cat comprising administering to the animal or cat said formulation of claim 22 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said dermatitis or said leukemia.
27. A method of treating flea bite dermatitis in an animal and feline leukemia in a cat comprising administering to the animal or cat said formulation of claim 6 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said dermatitis or said leukemia.
28. A method of treating strangles, chronic dust allergen cough or hypothyroidism in an animal comprising administering to the animal said formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said strangles, chronic dust allergen cough or hypothyroidism.
29. A method of treating lymphopenia in an animal comprising administering to the animal said formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said lymphopenia.
30. A method of reducing morbidity in young livestock animals comprising administering to said animals said formulation of claim 19 in an amount, at a frequency and for a duration effective to achieve at least a 30% reduction in morbidity as compared to controls.
31. The formulation of claim 19 further comprising pharmaceutically acceptable ionic salts or chelates of calcium, magnesium, sodium and potassium.
32. The formulation of claim 31 further comprising pharmaceutically acceptable citric acid.
33. The formulation of claim 32 further comprising Vitamins A, B2, B6, B12 C, E and thiamine.
34. A method of treating strangles, chronic dust allergen cough or hypothyroidism in an animal comprising administering to the animal said formulation of claim 31 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said strangles, chronic dust allergen cough or hypothyroidism.
35. A method of treating strangles, chronic dust allergen cough or hypothyroidism in an animal comprising administering to the animal said formulation of claim 32 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said strangles, chronic dust allergen cough or hypothyroidism.
36. A method of treating or strangles, chronic dust allergen cough or hypothvroidism in an animal comprising administering to the animal said formulation of claim 33 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said strangles, chronic dust allergen cough or hypothyroidism.
37. A method of treating lymphopenia in an animal comprising administering to the animal said formulation of claim 31 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said lymphopenia.
38. A method of treating lymphopenia in an animal comprising administering to the animal said formulation of claim 32 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said lymphopenia.
39. A method of treating lymphopenia in an animal comprising administering to the animal said formulation of claim 33 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said lymphopenia.
40. A method of reducing morbidity in young livestock animals comprising administering to the animals said formulation of claim 31 in an amount, at a frequency and for a duration effective to achieve at least a 40% reduction in morbidity as compared to controls.
41. A method of reducing morbidity in young livestock animals comprising administering to the animals said formulation of claim 33 in an amount, at a frequency and for a duration effective to achieve at least a 50% reduction in morbidity as compared to controls.
42. A formulation comprising pharmaceutically acceptable transfer factor and super oxide dismutase
43. The formulation of claim 42 further comprising a pharmaceutically acceptable glucosamine salt.
44. The formulation of claim 43 further comprising pharmaceutically acceptable chondroitin.
45. The formulation of claim 44 further comprising pharmaceutically acceptable glycine.
46. The formulation of claim 45 further comprising pharmaceutically acceptable methyl sulfonyl methane.
47. The formulation of claim 46 further comprising pharmaceutically acceptable boswellic acids.
48. The formulation of claim 46 further comprising pharmaceutically acceptable octocosonol and montmorillinite.
49. A formulation comprising pharmaceutically acceptable transfer factor and a pharmaceutically acceptable glucosamine salt.
50. A method of treating inflammation, arthritis or laminitis in an animal comprising administering to the animal said formulation of claim 42 in an amount, at a frequency and for a duration effective to reduce or eliminate said symptoms of said inflammation, arthritis, laminitis.
51. A method of treating inflammation, arthritis or laminitis in an animal comprising administering to the animal said formulation of claim 43 in an amount, at a frequency and for a duration effective to reduce or eliminate said symptoms of said inflammation, arthritis, laminitis.
52. A method of treating inflammation, arthritis or laminitis in an animal comprising administering to the animal said formulation of claim 46 in an amount, at a frequency and for a duration effective to reduce or eliminate said symptoms of said inflammation, arthritis, laminitis.
53. A method of treating inflammation, arthritis or laminitis in an animal comprising administering to the animal said formulation of claim 48 in an amount, at a frequency and for a duration effective to reduce or eliminate said symptoms of said inflammation, arthritis, laminitis, Cushings disease or syndrome.
54. A method of treating inflammation, arthritis or laminitis in an animal comprising administering to the animal said formulation of claim 49 in an amount, at a frequency and for a duration effective to reduce or eliminate said symptoms of said inflammation, arthritis, laminitis.
55. A method of treating a malignant tumor in an animal comprising administering to the animal said formulation of claim 42 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor.
56. A method of treating a malignant tumor in an animal comprising administering to the animal said formulation of claim 43 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor.
57. A method of treating a malignant tumor in an animal comprising administering to the animal said formulation of claim 46 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor.
58. A method of treating a malignant tumor in an animal comprising administering to the animal said formulation of claim 48 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor.
59. A method of treating a malignant tumor in an animal comprising administering to the animal said formulation of claim 49 in an amount, at a frequency and for a duration effective to reduce or eliminate said tumor.
60. A method of increasing weight gain and feed efficiency in livestock animals comprising administering to the animals said formulation of claim 19 in an amount, at a frequency and for a duration effective to achieve at least a 5.0% increase in weight of said animals as compared to controls.
61. A method of increasing weight gain and feed efficiency in livestock animals comprising administering to the animals said formulation of claim 20 in an amount, at a frequency and for a duration effective to achieve at least a 5.5% increase in weight of said animals as compared to controls.
62. A method of increasing weight gain and feed efficiency in livestock animals comprising administering to the animals said formulation of claim 31 in an amount, at a frequency and for a duration effective to achieve at least a 5.6% increase in weight of said animals as compared to controls.
63. A method of increasing weight gain and feed efficiency in livestock animals comprising administering to the animals said formulation of claim 32 in an amount, at a frequency and for a duration effective to achieve at least a 6.0% increase in weight of said animals as compared to controls.
64. A method of increasing weight gain and feed efficiency in livestock animals comprising administering to the animals said formulation of claim 33 in an amount, at a frequency and for a duration effective to achieve at least a 8.0% increase in weight of said animals as compared to controls.
65. The formulation of claim 20 further comprising pharmaceutically acceptable ionic salts or chelates of calcium, magnesium, sodium and potassium.
66. The formulation of claim 65 further comprising pharmaceutically acceptable citric acid.
67. The formulation of claim 66 further comprising Vitamins A, B2, B6, B12 C, E and thiamine.
68. A method of increasing weight gain and feed efficiency in livestock animals comprising administering to the animals said formulation of claim 65 in an amount, at a frequency and for a duration effective to achieve at least a 5.5% increase in weight of said animals as compared to controls.
69. A method of increasing weight gain and feed efficiency in livestock animals comprising adininistering to the animals said formulation of claim 66 in an amount, at a frequency and for a duration effective to achieve at least a 5.7% increase in weight of said animals as compared to controls.
70. A method of increasing weight gain and feed efficiency in livestock animals comprising administering to the animals said formulation of claim 67 in an amount, at a frequency and for a duration effective to achieve at least a 8.0% increase in weight of said animals as compared to controls.
71. A method of treating feline pneumonitis in a cat comprising administering to said cat the formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said pneumonitis.
72. A method of treating feline pneumonitis in a cat comprising administering to said cat the formulation of claim 20 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said pneumonitis.
73. A method of treating feline pneumonitis in a cat comprising administering to said cat the formulation of claim 31 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said pneumonitis.
74. A method of treating feline pneumonitis in a cat comprising administering to said cat the formulation of claim 32 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said pneumonitis.
75. A method of treating feline pneumonitis in a cat comprising administering to said cat the formulation of claim 33 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said pneumonitis.
76. A method of treating feline pneumonitis in a cat comprising administering to said cat the formulation of claim 65 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said pneumonitis.
77. A method of treating feline pneumonitis in a cat comprising administering to said cat the formulation of claim 66 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said pneumonitis.
78. A method of treating feline pneumonitis in a cat comprising administering to said cat the formulation of claim 67 in an amount, at a frequency and for a duration effective to reduce or eliminate symptoms of said pneumonitis.
79. A method of treating a Rhodococcus infection in an animal comprising administering to said animal the formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
80. A method of treating a Rhodococcus infection in an animal comprising administering to said animal the formulation of claim 20 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
81. A method of treating a Rhodococcus infection in an animal comprising administering to said animal the formulation of claim 31 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
82. A method of treating a Rhodococcus infection in an animal comprising administering to said animal the formulation of claim 32 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
83. A method of treating a Rhodococcus infection in an animal comprising administering to said animal the formulation of claim 33 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
84. A method of treating a Rhodococcus infection in an animal comprising administering to said animal the formulation of claim 65 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
85. A method of treating a Rhodococcus infection in an animal comprising administering to said animal the formulation of claim 66 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
86. A method of treating a Rhodococcus infection in an animal comprising administering to said animal the formulation of claim 67 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
87. A method of treating a Clostridium infection in an animal comprising administering to said animal the formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
88. A method of treating a Clostridium infection in an animal comprising administering to said animal the formulation of claim 20 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
89. A method of treating a Clostridium infection in an animal comprising administering to said animal the formulation of claim 31 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
90. A method of treating a Clostridium infection in an animal comprising administering to said animal the formulation of claim 32 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
91. A method of treating a Clostridium infection in an animal comprising administering to said animal the formulation of claim 33 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
92. A method of treating a Clostridium infection in an animal comprising administering to said animal the formulation of claim 65 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
93. A method of treating a Clostridium infection in an animal comprising administering to said animal the formulation of claim 66 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
94. A method of treating a Clostridium infection in an animal comprising administering to said animal the formulation of claim 67 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
95. A method of treating a coliform bacteria infection in an animal comprising administering to said animal the formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
96. A method of treating a coliform bacteria infection in an animal comprising administering to said animal the formulation of claim 20 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
97. A method of treating a coliform bacteria infection in an animal comprising administering to said animal the formulation of claim 31 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
98. A method of treating a coliform bacteria infection in an animal comprising administering to said animal the formulation of claim 32 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
99. A method of treating a coliform bacteria infection in an animal comprising administering to said animal the formulation of claim 33 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
100. A method of treating a coliform bacteria infection in an animal comprising administering to said animal the formulation of claim 65 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
101. A method of treating a coliform bacteria infection in an animal comprising administering to said animal the formulation of claim 66 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
102. A method of treating a coliform bacteria infection in an animal comprising administering to said animal the formulation of claim 67 in an amount, at a frequency and for a duration effective to reduce or eliminate said infection.
103. A method of treating bovine respiratory disease (BRD) in cattle comprising administering to an animal with BRD the formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce the symptoms of said disease.
104. A method of treating bovine respiratory disease (BRD) in cattle comprising administering to an animal with BRD the formulation of claim 20 in an amount, at a frequency and for a duration effective to reduce the symptoms of said disease.
105. A method of treating bovine respiratory disease (BRD) in cattle comprising administering to an animal with BRD the formulation of claim 31 in an amount, at a frequency and for a duration effective to reduce the symptoms of said disease.
106. A method of treating bovine respiratory disease (BRD) in cattle comprising administering to an animal with BRD the formulation of claim 32 in an amount, at a frequency and for a duration effective to reduce the symptoms of said disease.
107. A method of treating bovine respiratory disease (BRD) in cattle comprising administering to an animal with BRD the formulation of claim 33 in an amount, at a frequency and for a duration effective to reduce the symptoms of said disease.
108. A method of treating bovine respiratory disease (BRD) in cattle comprising administering to an animal with BRD) the formulation of claim 65 in an amount, at a frequency and for a duration effective to reduce the symptoms of said disease.
109. A method of treating bovine respiratory disease (BRD) in cattle comprising administering to an animal with BRD the formulation of claim 66 in an amount, at a frequency and for a duration effective to reduce the symptoms of said disease.
110. A method of treating bovine respiratory disease (BRD) in cattle comprising administering to an animal with BRD the formulation of claim 67 in an amount, at a frequency and for a duration effective to reduce the symptoms of said disease.
111. A method of treating circo virus disease in birds comprising administering to a bird infected with said virus the formulation of claim 19 in an amount, at a frequency and for a duration effective to reduce the symptoms of or eliminate said disease.
112. A method of treating circo virus disease in birds comprising administering to a bird infected with said virus the formulation of claim 20 in an amount, at a frequency and for a duration effective to reduce the symptoms of or eliminate said disease.
113. A method of treating circo virus disease in birds comprising administering to a bird infected with said virus the formulation of claim 31 in an amount, at a frequency and for a duration effective to reduce the symptoms of or eliminate said disease.
114. A method of treating circo virus disease in birds comprising administering to a bird infected with said virus the formulation of claim 32 in an amount, at a frequency and for a duration effective to reduce the symptoms of or eliminate said disease.
115. A method of treating circo virus disease in birds comprising administering to a bird infected with said virus the formulation of claim 33 in an amount, at a frequency and for a duration effective to reduce the symptoms of or eliminate said disease.
116. A method of treating circo virus disease in birds comprising administering to a bird infected with said virus the formulation of claim 65 in an amount, at a frequency and for a duration effective to reduce the symptoms of or eliminate said disease.
117. A method of treating circo virus disease in birds comprising administering to a bird infected with said virus the formulation of claim 66 in an amount, at a frequency and for a duration effective to reduce the symptoms of or eliminate said disease.
118. A method of treating circo virus disease in birds comprising administering to a bird infected with said virus the formulation of claim 67 in an amount, at a frequency and for a duration effective to reduce the symptoms of or eliminate said disease.